🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMy fatty liver reversal — November 2025 Page 5

My fatty liver reversal — November 2025

rachel_ABQ Mon, Dec 15, 2025 at 11:22 AM 33 replies 1,345 viewsPage 5 of 7
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Dec 22, 2025 at 6:47 AM#21
Dr.AddMedPHL said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Thank you for spelling out the reasoning rather than just the conclusion. Printing the relevant bit and taking it with me.

29 2andrew_nyc, Dr.EndoEP, GraceAZ_72 and 26 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Dec 22, 2025 at 9:27 PM#22

Adding the clinical framing, because it changes how the question reads. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

30 3Dr.NateNeph, PharmD_Rodriguez, julia.endo and 27 others
Reply Quote Save Share Report
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Dec 23, 2025 at 12:07 PM#23
andrew_nyc said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Second this. Nothing to add that would improve it.

Last edited: Dec 23, 2025 at 6:07 PM
31 4HPLC_Greg, LibrarianMeg, bri_stats and 28 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Dec 24, 2025 at 2:46 AM#24
andrew_nyc said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding the part of the answer the thread has not reached. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

Last edited: Dec 24, 2025 at 5:46 AM
32 5InsuranceTom, WendyG_ATL, SaraMom3 and 29 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Dec 24, 2025 at 5:25 PM#25

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

33 6jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 30 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register